These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26876898)

  • 1. Prostate cancer risk prediction and the persistence of uncertainty.
    Lundon DJ
    BJU Int; 2016 Mar; 117(3):382. PubMed ID: 26876898
    [No Abstract]   [Full Text] [Related]  

  • 2. Dutasteride and prostate cancer.
    Kiemeney LA; Bosland MC
    N Engl J Med; 2010 Aug; 363(8):793; author reply 794-5. PubMed ID: 20718671
    [No Abstract]   [Full Text] [Related]  

  • 3. What are the consequences if i postpone treatment of my PSA-detected prostate cancer?
    Sampson JN
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):727-8. PubMed ID: 21546364
    [No Abstract]   [Full Text] [Related]  

  • 4. Dutasteride and prostate cancer.
    Schröder FH; Roobol MJ
    N Engl J Med; 2010 Aug; 363(8):793-4; author reply 794-5. PubMed ID: 20842789
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemoprevention of prostate cancer.
    Walsh PC
    N Engl J Med; 2010 Apr; 362(13):1237-8. PubMed ID: 20357287
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary European cohort.
    Poyet C; Nieboer D; Bhindi B; Kulkarni GS; Wiederkehr C; Wettstein MS; Largo R; Wild P; Sulser T; Hermanns T
    BJU Int; 2016 Mar; 117(3):401-8. PubMed ID: 26332503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial comment.
    Kibel AS
    J Urol; 2010 Feb; 183(2):533; discussion 533. PubMed ID: 20006889
    [No Abstract]   [Full Text] [Related]  

  • 8. Dutasteride and prostate cancer.
    Klotz L
    N Engl J Med; 2010 Aug; 363(8):794; author reply 795-6. PubMed ID: 20842791
    [No Abstract]   [Full Text] [Related]  

  • 9. Transrectal US of the prostate: is the technology leading the science?
    McClennan BL
    Radiology; 1988 Aug; 168(2):571-5. PubMed ID: 3293115
    [No Abstract]   [Full Text] [Related]  

  • 10. Dutasteride and prostate cancer.
    Garattini S; Bertele' V
    N Engl J Med; 2010 Aug; 363(8):794; author reply 794-6. PubMed ID: 20842790
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of prostate cancer with finasteride.
    Burke HB
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562806
    [No Abstract]   [Full Text] [Related]  

  • 12. Comments on: Saturation biopsy for detecting and characterizing prostate cancer; and A review of targeted screening for prostate cancer: introducing the IMPACT study.
    Pitt WR
    BJU Int; 2008 Feb; 101(3):392. PubMed ID: 18184333
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of prostate cancer with finasteride.
    Schwartz DT
    N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562808
    [No Abstract]   [Full Text] [Related]  

  • 14. Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy.
    Nguyen CT; Yu C; Moussa A; Kattan MW; Jones JS
    J Urol; 2010 Feb; 183(2):529-33. PubMed ID: 20006887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine screening for prostate cancer using the digital rectal examination.
    Chodak GW; Keller P; Schoenberg H
    Prog Clin Biol Res; 1988; 269():87-98. PubMed ID: 3393557
    [No Abstract]   [Full Text] [Related]  

  • 16. Statins may slow prostate growth.
    Printz C
    Cancer; 2012 Sep; 118(18):4369. PubMed ID: 22952030
    [No Abstract]   [Full Text] [Related]  

  • 17. Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma.
    Lee F; Torp-Pedersen ST; Siders DB; Littrup PJ; McLeary RD
    Radiology; 1989 Mar; 170(3 Pt 1):609-15. PubMed ID: 2644656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening for prostatic cancer].
    Pushkar' DIu; Govorov AV; Bormotin AV
    Urologiia; 2003; (1):10-5. PubMed ID: 12621959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prostate Cancer Prevention Trial and European Randomized Study of Screening for Prostate Cancer risk calculators indicating a positive prostate biopsy: a comparison.
    van den Bergh RC; Roobol MJ; Wolters T; van Leeuwen PJ; Schröder FH
    BJU Int; 2008 Nov; 102(9):1068-73. PubMed ID: 18715246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 18th International Symposium: Controversies in Prostate Cancer Diagnosis and Treatment.
    Pu YS; Fujimoto H; Kakizoe T; Myers R
    Jpn J Clin Oncol; 2005 Nov; 35(11):680-9. PubMed ID: 16275675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.